Loading clinical trials...
Loading clinical trials...
Cannabis users who experienced a psychosis are particularly vulnerable to cannabis-related harms, which can include worse psychotic symptoms and more hospitalizations. Unfortunately, few psychosocial ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborators
NCT07471685 · Cancer Survivorship, Family Planning, and more
NCT06743711 · Severe Mental Illness, Schizophrenia Spectrum &Amp; Other Psychotic Disorders, and more
NCT06563245 · Classical Hodgkin Lymphoma, Child, and more
NCT07455929 · Psychotic Disorders, Schizophrenia Spectrum Disorders
NCT07460453 · Paranoia, Psychotic Disorders
Foothills Medical Centre Early Psychosis Intervention Program, Unit 24, 1403-29 Street NW
Calgary, Alberta
Nova Scotia Early Psychosis Program, 3rd Floor, Abbie Lane Bldg 5909 Veterans' Memorial Lane
Halifax, Nova Scotia
Clinic Connec-T - Institut universitaire en santé mentale de Montréal, 7401 rue Hochelaga
Montreal, Quebec
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions